Active Ingredient(s): Riluzole
FDA Approved: * September 5, 2018
Pharm Company: * ITALFARMACO SPA
Category: Neurological Disorders

Riluzole is a medication used to treat amyotrophic lateral sclerosis and other motor neurone diseases. Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months.[2] Riluzole is available in tablet and liquid form. Contents 1 Medical use 1.1 Amyotrophic lateral sclerosis 2 Adverse effects 2.1 Overdose 3 Contraindications 3.1 Interactions 4 Mechanism of action 5 Synthesis 6 Society and culture 6... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tiglutik 50 mg/10ml Oral Liquid
NDC: 70726-0304
Edw Pharma, Inc

Related Brands

Drugs with the same active ingredients